pharmacovigilance (PV)

1 article · search the full text for this term

• Published Subscription Review Article 20 Jan 2025

  Artificial Intelligence in Pharmacovigilance: Improving Drug Safety

  By Mohd. Wasiullah, Piyush Yadav, Satish Kumar Yadav, Rishabh Chauhan

  Abstract: Artificial intelligence (AI) is revolutionizing pharmacovigilance (PV) by enhancing the detection, assessment, and prevention of adverse drug reactions (ADRs). This review examines how AI technologies – such as machine learning (ML), natural language processing (NLP), and big data analytics – tackle existing challenges in pharmacovigilance (PV), including issues like underreporting, large data volumes, and inefficiencies in data processing. AI improves drug safety by automating data collection, enabling real-time adverse event …

  Published in Research and Reviews : Journal of Computational Biology · Vol. 14, Issue 1, 2025 · pp. 1–16 Read article →